Ho Jun Chin Selected Research

Sodium-Restricted Diet (Diet, Sodium Restricted)

1/2019	Long-Term Effects of Intensive Low-Salt Diet Education on Deterioration of Glomerular Filtration Rate among Non-Diabetic Hypertensive Patients with Chronic Kidney Disease.
12/2018	Estimating the urinary sodium excretion in patients with chronic kidney disease is not useful in monitoring the effects of a low-salt diet.
12/2014	Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.
1/2014	A low-salt diet increases the estimated net endogenous acid production in nondiabetic chronic kidney disease patients treated with angiotensin receptor blockade.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ho Jun Chin Research Topics

Disease

15	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 01/2012
15	Chronic Renal Insufficiency 01/2021 - 06/2010
14	Proteinuria 01/2021 - 01/2009
13	Hypertension (High Blood Pressure) 01/2021 - 01/2009
13	Albuminuria 01/2019 - 01/2009
12	IGA Glomerulonephritis (IGA Nephropathy) 12/2020 - 12/2005
11	Chronic Kidney Failure (Chronic Renal Failure) 07/2020 - 01/2009
7	Inflammation (Inflammations) 01/2016 - 01/2012
6	Kidney Diseases (Kidney Disease) 12/2021 - 06/2012
6	Diabetes Mellitus 01/2019 - 01/2009
5	Anemia 01/2021 - 01/2012
4	Neoplasms (Cancer) 10/2020 - 01/2011
4	Hyponatremia 01/2019 - 01/2016
3	Lupus Nephritis 08/2020 - 03/2012
3	Critical Illness (Critically Ill) 09/2018 - 01/2012
3	Insulin Resistance 01/2017 - 06/2010
3	Glomerulonephritis 01/2016 - 12/2005
3	Hypoxia (Hypoxemia) 09/2014 - 01/2012
2	Hypotension (Low Blood Pressure) 09/2022 - 01/2013
2	Fibrosis (Cirrhosis) 10/2021 - 01/2012
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 06/2012
2	Obesity 11/2018 - 01/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2015 - 01/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 09/2014 - 06/2010
2	Dyslipidemias (Dyslipidemia) 09/2014 - 01/2014
2	Wounds and Injuries (Trauma) 09/2014 - 05/2012
1	Sarcopenia 09/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Acute Tubulointerstitial Nephritis 12/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 06/2019
1	Hypocalcemia 06/2019
1	Seizures (Absence Seizure) 06/2019
1	Tuberous Sclerosis (Bourneville's Disease) 06/2019
1	Hyperphosphatemia 01/2019
1	Vascular Calcification 01/2019
1	Hypoalbuminemia 01/2019
1	Infections 05/2018
1	Weight Loss (Weight Reduction) 03/2018
1	Arteriovenous Fistula 01/2018

Drug/Important Bio-Agent (IBA)

25	CreatinineIBA 12/2021 - 01/2009
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
8	SodiumIBA 12/2018 - 01/2014
6	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2012
5	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 06/2012
5	SaltsIBA 01/2019 - 09/2014
5	AlbuminsIBA 01/2018 - 01/2009
5	BilirubinIBA 09/2014 - 01/2009
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 03/2012
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2012
4	SteroidsIBA 01/2021 - 06/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 09/2014
4	Phosphorus (Red Phosphorus)IBA 01/2019 - 07/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2014 - 01/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 03/2012
3	Uric Acid (Urate)IBA 07/2020 - 06/2010
3	Serum AlbuminIBA 01/2020 - 01/2009
3	ORALIT (ORS)IBA 01/2019 - 06/2014
3	Angiotensin Receptor AntagonistsIBA 05/2018 - 01/2015
3	olmesartanIBA 01/2015 - 01/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2021 - 01/2016
2	Prednisolone (Predate)FDA LinkGeneric 01/2021 - 06/2012
2	NitrogenIBA 01/2021 - 11/2015
2	Urea (Carbamide)FDA LinkGeneric 01/2021 - 11/2015
2	Immunoglobulin A (IgA)IBA 08/2020 - 07/2011
2	AngiotensinsIBA 01/2019 - 01/2018
2	ElectrolytesIBA 09/2018 - 01/2017
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 05/2018 - 01/2011
2	C-Reactive ProteinIBA 09/2017 - 06/2010
2	Biomarkers (Surrogate Marker)IBA 08/2015 - 02/2013
2	Triglycerides (Triacylglycerol)IBA 09/2014 - 05/2010
2	Streptozocin (Streptozotocin)FDA Link 09/2014 - 12/2010
2	AntioxidantsIBA 04/2013 - 01/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2012 - 03/2012
2	Erythropoietin FDA Link 05/2012 - 01/2012
2	CobaltIBA 01/2012 - 01/2012
1	Complement System Proteins (Complement)IBA 12/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	empagliflozinIBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	CytokinesIBA 12/2019
1	Vitamin D FDA LinkGeneric 06/2019
1	CalciumIBA 06/2019
1	trans-sodium crocetinate (crocetin)IBA 06/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 06/2019
1	AldosteroneIBA 01/2019
1	MineralsIBA 01/2019
1	ReninIBA 01/2019
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2019

Therapy/Procedure

6	Therapeutics 10/2020 - 07/2011
5	Renal Dialysis (Hemodialysis) 09/2022 - 03/2012
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 11/2018 - 05/2012
4	Sodium-Restricted Diet (Diet, Sodium Restricted) 01/2019 - 01/2014
3	Aftercare (After-Treatment) 01/2018 - 01/2015
2	Continuous Renal Replacement Therapy 12/2019 - 09/2018
2	Extracorporeal Membrane Oxygenation 09/2018 - 01/2015
2	Activities of Daily Living (ADL) 01/2016 - 01/2013
1	Remission Induction 01/2021
1	Diet Therapy (Therapy, Diet) 01/2019
1	General Anesthesia 08/2018
1	Conservative Treatment 05/2018